Clearside Biomedical, Inc.

Clearside Biomedical, Inc. - ROEverified

CLSD

Price:

$0.41

Market Cap:

$1.41M

Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to pioneering novel drug delivery methods to the posterior segment of the eye via the suprachoroidal space. Its commercial product, XIPERE, is a triamcinolone acetonide suprachoroidal injectable suspension designed for treating uveitis macular edema. The company's development pipeline also features CLS-AX, an axitinib injectable suspension administered into the suprachoroidal space, which is currently undergoing Phase 1/2a clinical trials. Additionally, they are advancing CLS-301, an integrin inhibitor suspension aimed at addressing diabetic macular edema and macular degeneration. Clearside maintains strategic partnerships w...[Read more]

Industry

Biotechnology

IPO Date

2016-06-02

Stock Exchange

NASDAQ

Ticker

CLSD

The ROE as of June 2026 (TTM) for Clearside Biomedical, Inc. (CLSD) is 55.47%

According to Clearside Biomedical, Inc.’s latest financial reports and current stock price. The company's current ROE is 55.47%. This represents a change of 289.24% compared to the average of 14.25% of the last 4 quarters.

Clearside Biomedical, Inc. (CLSD) Historical ROE (quarterly & annually)

How has CLSD ROE performed in the past?

The mean historical ROE of Clearside Biomedical, Inc. over the last ten years is -132.83%. The current 55.47% ROE has changed -141.76% with respect to the historical average. Over the past ten years (40 quarters), CLSD's ROE was at its highest in in the June 2023 quarter at 183.11%. The ROE was at its lowest in in the March 2023 quarter at -343.70%.

Quarterly (TTM)
Annual

Average

-132.83%

Median

-186.68%

Minimum

-350.63%

Maximum

204.15%

Clearside Biomedical, Inc. (CLSD) ROE by Quarter and Year

Discovering the peaks and valleys of Clearside Biomedical, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 662.47%

Maximum Annual ROE = 204.15%

Minimum Annual Increase = -31471.35%

Minimum Annual ROE = -350.63%

Quarterly (TTM)
Annual
YearROEChange
202488.41%-56.69%
2023204.15%-165.73%
2022-310.62%-31471.35%
20210.99%-100.48%
2020-207.81%-24.65%
2019-275.79%-21.34%
2018-350.63%27.32%
2017-275.39%662.47%
2016-36.12%-78.18%
2015-165.55%-412.16%

Clearside Biomedical, Inc. (CLSD) Average ROE

How has CLSD ROE performed in the past?

The current ROE of Clearside Biomedical, Inc. (CLSD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.02%

5-year avg

-44.97%

10-year avg

-132.83%

Clearside Biomedical, Inc. (CLSD) ROE vs. Peers

How is CLSD’s ROE compared to its peers?

Clearside Biomedical, Inc.’s ROE is less than CASI Pharmaceuticals, Inc. (358.32%), greater than Cingulate Inc. (-365.16%), greater than Lexaria Bioscience Corp. (-190.06%), greater than Lisata Therapeutics, Inc. (-101.90%), greater than Allarity Therapeutics, Inc. (-109.94%), greater than Pelthos Therapeutics Inc. (-164.11%), greater than Entero Therapeutics, Inc. (-18.69%), greater than Kairos Pharma, Ltd. (-92.26%), greater than MetaVia Inc. (-172.92%), greater than Palisade Bio, Inc. (-36.79%),

Build a custom stock screener for Clearside Biomedical, Inc. (CLSD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clearside Biomedical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clearside Biomedical, Inc. (CLSD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clearside Biomedical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Clearside Biomedical, Inc.'s ROE?

How is the ROE calculated for Clearside Biomedical, Inc. (CLSD)?

What is the highest ROE for Clearside Biomedical, Inc. (CLSD)?

What is the 3-year average ROE for Clearside Biomedical, Inc. (CLSD)?

What is the 5-year average ROE for Clearside Biomedical, Inc. (CLSD)?

How does the current ROE for Clearside Biomedical, Inc. (CLSD) compare to its historical average?